Business Vaccinoma To Raise $ 17m In New IPO – phase III human trial phaseVaccinoma Inc is slated to be at least $ increasing 17,000 through a public offering to go out to III studies human phase of its melanoma cancer vaccine and a breast cancer vaccine to Phase I human trials.

The company has 17 million shares of $ 1 each with allowance for an additional 8 million shares for oversubscriptions. Pegasus Corporate Advisors in Australia is the lead manager with Sudbrook Associates in London at the head of European distribution syndicate. The company is a market capitalization of $ 43,000 list. ASX is expected in June.The information was with permission on the Henry J. Kaiser Family Foundation to can enjoy the full Kaiser Daily U.S. HIV / AIDS Reports, e-mailh the archives and log in on e-mail supply to daily reports.

Governor Schwarzenegger proposed over $ 80 million in sections of for HIV / AIDS programs , including the government AIDS Drug Assistance programming and formation and prevention programs, proposes a number, the state legislature of the Common Budget Conference Committee, be reduced 000 must. The Rainbow Alliance serves 350 clients and delivers emergency shelter, pantry, spirit health consultation and the case Management Programme – all of which could be budget cutbacks budget cuts. The legislator hopes that a final by the end by the end the month of (Guerrero, Ventura County Star..

Other articles from "plastic surgery":

Random articles